Abstract

INTRODUCTION AND OBJECTIVES: Muscle-invasive urothelial carcinoma of the urinary bladder (UCUB) is an aggressive disease. The standard treatment of care is radical cystectomy (RC). Trimodal bladder-preserving treatment (BPT), including transurethral resection of the bladder tumor, radiation, and chemotherapy has gained considerable interest. We sought to perform a comparative effectiveness assessment of RC vs. BPT in a stage-for-stage analysis. METHODS: We performed a retrospective cohort study of Medicare beneficiaries with non-metastatic muscle-invasive (T2eT4a, N0) UCUB treated with RC or BPT from 1991 to 2009. Following instrumental variable analysis that accounts for both measured and unmeasured confounders, multivariable Coxand competing-risks regression two-stage residual inclusions models were fitted. All analyses were stratified according to disease stage (organ-confined vs. non-organ confined). Our primary outcomes were overall survival (OS) and cancer-specific mortality (CSM). RESULTS: Overall 4168 patients with muscle-invasive UCUB were identified, where 3488 (84%) underwent RC and 680 (16%) received BPT, respectively. During the entire study span, the 5-year OS rates for RC and BPT were 42.9% (95% confidence interval [CI]1⁄441 to 45%) and 21.8% (95% CI1⁄419 to 26%), respectively. Five-year CSM rates were 34.0% (95% CI1⁄432 to 36) and 47.6% (95% CI1⁄444 to 52) for the same groups, respectively. In patients with organ-confined UCUB (T2N0), BPTtreated individuals had significantly increased risks of mortality (hazard ratio [HR]: 1.49, 95% CI1⁄41.04e2.13, P1⁄40.031) and CSM (HR: 1.66, 95% CI1⁄41.03e2.67, P1⁄40.036) compared to RC patients. Among those with non-organ confinedUCUB ( T3N0), no differencewas noted with respect to OS (HR: 1.22, 95%CI1⁄40.62e2.40, P1⁄40.571) and CSM (HR: 1.13, 95% CI1⁄40.48e2.64, P1⁄40.780) between the two groups. CONCLUSIONS: RC was associated with improved cancer control outcomes compared to BPT in organ-confined UCUB. However, no difference between the two treatment modalities was observed with respect to survival amongst patients with more advanced disease stage.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call